MRI scans could replace invasive heart tests for lung disease patients
NCT ID NCT05624242
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether cardiac MRI can accurately measure right heart function in 112 people with pulmonary arterial hypertension. Researchers compared MRI results with data from invasive heart catheterization. The goal was to see if MRI could be used to monitor disease and predict outcomes like need for transplant or death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use MRI instead of invasive catheterization to monitor heart function in pulmonary hypertension patients.
- What could go wrong
- This is an observational study, not a treatment trial. It may not change current practice if MRI does not prove reliable enough to replace invasive testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Simon Valentin
Nancy, Grand Est, 54000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill ease the strain of pulmonary arterial hypertension?
- A tiny sensor inside the lung could reveal hidden pressure problems after Life-Saving surgery
- Could a gut bacteria transplant ease a rare lung disease?
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?
- Can a smartwatch replace the clinic walk test for lung disease patients?
- Blood particles may reveal hidden clues to scleroderma complications